ReviewJournal of neurology2015
Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions.
Review in Journal of neurology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 35 citations in OpenAlex.
- Micro-Engineered Smart ZnO Inverse Opal Electrodes with AgCuS Nanocrystal Amplification for Ultrasensitive Anti-LGI1 Antibody Detections.Micromachines · 2026Article
- AAV Vector-Mediated Modulation of Signaling Pathways in Neurological Disorders: Insights From Cellular, Animal, and Human Studies.Cell biochemistry and function · 2026Review
- Time moving 100-fold slower: time distortion as a diagnostic clue in anti-NMDA receptor encephalitis.BMC neurology · 2025Article
- Autoimmune encephalitis: recent clinical and biological advances.Journal of neurology · 2023Article
- The autoantibody-mediated encephalitides: from clinical observations to molecular pathogenesis.Journal of neurology · 2021Review
- The B cell immunobiology that underlies CNS autoantibody-mediated diseases.Nature reviews. Neurology · 2020Review
- Use of intravenous immunoglobulin for the treatment of autoimmune encephalitis: audit of the NHS experience.JRSM open · 2018Article
- The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disorders.Movement disorders : official journal of the Movement Disorder Society · 2018Review
- LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes.Journal of neurology, neurosurgery, and psychiatry · 2018Review
- Seronegative antibody-mediated neurology after immune checkpoint inhibitors.Annals of clinical and translational neurology · 2018Article
- Diagnosing MRI-negative autoimmune diseases.Neurology(R) neuroimmunology & neuroinflammation · 2018Article
- High prevalence of neuronal surface autoantibodies associated with cognitive deficits in cancer patients.Journal of neurology · 2017Article
- Innate and adaptive immunity in human epilepsies.Epilepsia · 2017Review
- Electroconvulsive therapy and/or plasmapheresis in autoimmune encephalitis?World journal of clinical cases · 2016Article
- Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications.Psychopharmacology · 2016Review
- 'Moonlighting' surface antigens: a paradigm for autoantibody pathogenicity in neurology?Brain : a journal of neurology · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
The field of neuronal surface-directed antibody-mediated diseases of the central nervous system has dramatically expanded in the last few years and now forms an important cluster of treatable neurological conditions. In this review, we focus on three areas. First, we review the demographics, clinical features and treatment responses of these conditions. Second, we consider their pathophysiology and compare autoantibody mechanisms and their effects to genetic or pharmacological disruptions of the target antigens. Third, we discuss areas of controversy within the field, propose possible resolutions, and explore new directions for neuronal surface antibody-mediated diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.